Conversion of highly malignant colon cancer from an aggressive to a controlled disease by oral administration of a metalloproteinase inhibitor
- 1 January 1997
- journal article
- Published by Springer Nature in Clinical & Experimental Metastasis
- Vol. 15 (2) , 184-195
- https://doi.org/10.1023/a:1018461112732
Abstract
In this study, we describe the activity of CT1746, an orally-active synthetic MMP inhibitor that has a greater specificity for gelatinase A, gelatinase B and stromelysin than for interstitial...Keywords
This publication has 30 references indexed in Scilit:
- An in Vivo Model for Screening Peptidomimetic Inhibitors of Gelatinase AJournal of Pharmaceutical Sciences, 1995
- Reciprocated matrix metalloproteinase activation: A process performed by interstitial collagenase and progelatinase ABiochemistry, 1994
- Orthotopic is orthodox: Why are orthotopic‐transplant metastatic models different from all other models?Journal of Cellular Biochemistry, 1994
- Cancer metastasis and angiogenesis: An imbalance of positive and negative regulationCell, 1991
- Control of differentiation in human colorectal carcinoma cell lines: Epithelial—mesenchymal interactionsThe Journal of Pathology, 1988
- Interactions with host macrophages and ability of human melanoma cell lines to grow in nude miceInternational Journal of Cancer, 1986
- The pharmacology and clinical uses of tamoxifenPharmacology & Therapeutics, 1984
- INTERFERON, NK CELLS AND PERSISTENT VIRUS INFECTION*Annals of the New York Academy of Sciences, 1980
- Specificity of cytotoxic T cells from athymic mice.The Journal of Experimental Medicine, 1980
- Augmentation of natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic target cellsInternational Journal of Cancer, 1977